Are physicians neglecting the risk of heart failure in diabetic patients who are receiving sulfonylureas? Lessons from the TOSCA.IT trial

Publisher： John Wiley & Sons Inc

E-ISSN： 1879-0844|20|1|49-51

ISSN： 1388-9842

Source： EUROPEAN JOURNAL OF HEART FAILURE, Vol.20, Iss.1, 2018-01, pp. : 49-51

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Predicting survival in heart failure: validation of the MAGGIC heart failure risk score in 51 043 patients from the Swedish Heart Failure Registry

By  

EUROPEAN JOURNAL OF HEART FAILURE, Vol. 16, Iss. 2, 2014-02 ,pp. : 173-179

John Wiley & Sons Inc

Access to resources Recommend Favorite

Who Protects Physicians and Patients from Guidelines?

By  

Cardiology, Vol. 121, Iss. 1, 2012-03 ,pp. : 56-58

Karger

Access to resources Recommend Favorite

Is heart rate a risk marker in patients with chronic heart failure and concomitant atrial fibrillation? Results from the MAGGIC meta‐analysis

By  

EUROPEAN JOURNAL OF HEART FAILURE, Vol. 17, Iss. 11, 2015-11 ,pp. : 1182-1191

John Wiley & Sons Inc

Access to resources Recommend Favorite

Galectin‐3 in patients with heart failure with preserved ejection fraction: results from the Aldo‐DHF trial

By  

EUROPEAN JOURNAL OF HEART FAILURE, Vol. 17, Iss. 2, 2015-02 ,pp. : 214-223

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prevalence and Prognostic Impact of Chronic Obstructive Pulmonary Disease in Patients with Chronic Heart Failure: Data from the GISSI-HF Trial

By  

Cardiology, Vol. 136, Iss. 2, 2016-09 ,pp. : 128-137

Karger

Access to resources Recommend Favorite